Living Health Technology Assessment: Issues, Challenges and Opportunities.

Living Health Technology Assessment: Issues, Challenges and Opportunities.
复制标题

DOI:
10.1007/s40273-022-01229-4
复制
发表时间:
2023-03
期刊:
影响因子:
4.4
通讯作者:
Uttley, Lesley
Uttley, Lesley
中科院分区:
医学2区
文献类型:
--
作者:
Thokala, Praveen;Srivastava, Tushar;Smith, Robert;Ren, Shijie;Whittington, Melanie D.;Elvidge, Jamie;Wong, Ruth;Uttley, Lesley

文献摘要

参考文献

被引文献

相似文献

卫生技术评估通常作为一次性评估进行,并且可能由于新数据、新比较物或其他因素的可用性而过时。最近,活体方法已应用于系统评价和网络荟萃分析,使证据合成更容易更新。在本文中,我们为“活的HTA”提供了一个定义,其中这种活的方法可以应用于整个HTA过程。实时HTA可以包括使用传统的手动方法执行定期或计划的更新,或者实际上以半自动化的方式利用最近的技术创新,使HTA过程的部分自动化。描述了使用两种方法(即手动方法和使用半自动化方法)的活体HTA的实际实施,以及规划和实施活体HTA过程中可能出现的问题和挑战。所概述的时间、资源和其他考虑因素可能会阻止活体HTA成为每次评估的标准;然而,讨论了活体HTA特别有益的情况。
Health technology assessments (HTAs) are typically performed as one-off evaluations and can potentially become out-of-date due to the availability of new data, new comparators, or other factors. Recently, living approaches have been applied to systematic reviews and network meta-analyses to enable evidence syntheses to be updated more easily. In this paper, we provide a definition for ‘Living HTA’ where such a living approach could be applied to the entire HTA process. Living HTA could involve performing regular or scheduled updates using a traditional manual approach, or indeed in a semi-automated manner leveraging recent technological innovations that automate parts of the HTA process. The practical implementation of living HTA using both approaches (i.e., manual approach and using semi-automation) is described along with the likely issues and challenges with planning and implementing a living HTA process. The time, resources and additional considerations outlined may prohibit living HTA from becoming the norm for every evaluation; however, scenarios where living HTA would be particularly beneficial are discussed.
DOI: 10.1136/bmj.b2535
发表时间: 2009-07-21
期刊: BMJ (Clinical research ed.)
影响因子: --
作者:
Moher D;Liberati A;Tetzlaff J;Altman DG;PRISMA Group
通讯作者: PRISMA Group
DOI: 10.1007/s40273-021-01116-4
发表时间: 2021-12-06
期刊: PHARMACOECONOMICS
影响因子: 4.4
作者:
Shields, Gemma E.;Pennington, Becky;Elvidge, Jamie
通讯作者: Elvidge, Jamie
DOI: 10.1093/jamia/ocv044
发表时间: 2016-01-01
影响因子: 6.4
作者:
Marshall, Iain J.;Kuiper, Joel;Wallace, Byron C.
通讯作者: Wallace, Byron C.
DOI: 10.1136/bmjopen-2016-012545
发表时间: 2017-02-27
期刊: BMJ open
影响因子: 2.9
作者:
Borah R;Brown AW;Capers PL;Kaiser KA
通讯作者: Kaiser KA
DOI: 10.1093/jamia/ocaa163
发表时间: 2020-12-09
期刊: Journal of the American Medical Informatics Association : JAMIA
影响因子: --
作者:
Marshall IJ;Nye B;Kuiper J;Noel-Storr A;Marshall R;Maclean R;Soboczenski F;Nenkova A;Thomas J;Wallace BC
通讯作者: Wallace BC